Recall of Fasenra Pen 30 mg/mL Batch
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Fasenra pen 30MG/ML Benralizumab 0212222960 YK0060 AstraZeneca Pharmaceuticals LP
التصنيف
ملف
التاريخ
2025-12-29
اسم المستحضر
Fasenra pen 30MG/ML
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The Saudi Food and Drug Authority (SFDA) has issued a recall for one batch of the Fasenra Pen 30 mg/mL product due to its non-compliance with the approved product specifications.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。